Market News - Page 592

AstraZeneca today announced that the US Food and Drug Administration (FDA) has accepted a supplemental Biologics License Application (sBLA) and granted Priority Review for Imfinzi (durvalumab) for the treatment of patients with previously untreated extensive-stage small cell lung cancer (SCLC).

…

Benchmark, the aquaculture health, nutrition and genetics business, provides the following trading update for its fourth quarter and year ended 30 September 2019 ahead of the publication of its full year results in the week ending 20 December 2019.

…

Grainger agrees to forward fund and acquire a 132 home, PRS development at Hallsville Quarter in Canning Town, London for c.£55.5m

…

James Fisher and Sons Plc (“James Fisher” or “the Group”), the UK's leading marine services company, issues its trading update for the period ended 30 September 2019 (“the period”)….

James Latham Plc issue half year report for year ended 30 September …

Brewin Dolphin Holdings Plc issue Preliminary Report For the Year Ended 30 September 2019…

Grainger Plc, the UK's largest listed provider of private rental housing, today announces its financial results for the year to 30 September 2019.

…

Appreciate Group Plc the UK's leading multi-retailer, multi-channel gift voucher and prepaid gift card provider, is pleased to announce its half year results for the six months ended 30 September 2019. Appreciate's business is highly seasonal; the first half of the year sees an expected loss with the majority of annual revenues and profit generated in the second half of the year….